Beacon Biosignals

Beacon Biosignals is a company that powers precision medicine for the brain through its EEG neurobiomarker platform. This platform is designed to accelerate clinical trials and enable new treatments for patients with neurological and psychiatric diseases. By capturing EEG data in real time, Beacon Biosignals can assess treatment efficacy, understand pharmacokinetics and pharmacodynamics, and facilitate population stratification. Their services optimize clinical trials by demonstrating target engagement, guiding dose selection, and employing quantitative endpoints. They partner with biopharma companies, academic medical centers, and neurotechnology developers to enhance the diagnosis and treatment of neurological and psychiatric conditions.